VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $753,478 | -63.7% | 80,414 | -9.9% | 0.00% | -100.0% |
| Q2 2023 | $2,076,685 | 0.0% | 89,243 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,076,685 | +14.4% | 89,243 | +24.4% | 0.00% | 0.0% |
| Q4 2022 | $1,815,864 | -99.9% | 71,745 | +13.5% | 0.00% | 0.0% |
| Q3 2022 | $1,219,094,000 | -39.1% | 63,231 | -19.5% | 0.00% | 0.0% |
| Q2 2022 | $2,001,076,000 | +15.3% | 78,566 | +16.4% | 0.00% | 0.0% |
| Q1 2022 | $1,735,585,000 | -36.3% | 67,480 | +3.7% | 0.00% | 0.0% |
| Q4 2021 | $2,723,309,000 | -1.8% | 65,042 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $2,773,050,000 | -7.2% | 63,719 | +0.9% | 0.00% | 0.0% |
| Q2 2021 | $2,986,677,000 | +479.1% | 63,170 | +528.0% | 0.00% | – |
| Q1 2021 | $515,725,000 | +91.4% | 10,059 | 0.0% | 0.00% | – |
| Q4 2020 | $269,380,000 | -93.9% | 10,059 | -92.2% | 0.00% | -100.0% |
| Q3 2020 | $4,403,097,000 | -28.3% | 128,258 | -14.4% | 0.00% | -50.0% |
| Q2 2020 | $6,139,641,000 | – | 149,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |